No connection

Search Results

MRX

NEUTRAL
$53.2 Live
Marex Group plc · NASDAQ
Target $55.0 (+3.4%)
$27.91 52W Range $53.64

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 15, 2026
Market cap
$3.82B
P/E
13.57
ROE
27.5%
Profit margin
10.7%
Debt/Equity
9.88
Dividend yield
1.14%

AI Analysis

AI-powered fundamental assessment

Confidence
80%
MRX presents a complex profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant valuation gap between its Graham Number ($37.87) and Intrinsic Value ($115.64). While the company exhibits exceptional ROE (27.48%) and strong EPS growth, these are offset by a critical Debt/Equity ratio of 9.88 and a severe YoY revenue decline of 51.40%. The stock is currently trading at a discount to its growth-based intrinsic value, but bearish insider sentiment and high leverage warrant a cautious approach.

Key Strengths

Very high Return on Equity (ROE) of 27.48% compared to sector average
Attractive valuation with a Forward P/E of 10.02
Strong quarterly earnings momentum with 50.40% Q/Q growth
Significant price appreciation over the last 6 months (+70.5%)
Sustainable dividend payout ratio of 15.27%

Key Risks

Extreme leverage with a Debt/Equity ratio of 9.88
Severe YoY revenue contraction of 51.40%
Bearish insider activity with $1.20M in sales and zero buys
Low liquidity indicated by a Quick Ratio of 0.74
Technical trend score (10/100) suggests underlying bearishness despite recent price spikes
AI Fair Value Estimate
Based on comprehensive analysis
$76.75
+44.3% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
61
Strong
Value
85
Future
60
Past
90
Health
30
Dividend
40
AI Verdict
Speculative Value
Key drivers: High ROE, Extreme Debt/Equity, EPS Growth vs Revenue Decline, Low P/E
Confidence
85%
Value
85/100

Ref P/E, PEG, Graham Number

Positives
  • P/E (13.57) is significantly lower than sector average (48.59)
  • Trading well below growth-based intrinsic value ($115.64)
Watchpoints
  • Trading above the defensive Graham Number ($37.87)
Future
60/100

Ref Growth rates

Positives
  • Strong Q/Q revenue and earnings recovery
  • Consistent earnings beats in recent quarters
Watchpoints
  • Devastating YoY revenue growth (-51.40%)
Past
90/100

Ref Historical trends

Positives
  • Exceptional 1Y (+40.5%) and 6M (+70.5%) price performance
  • Strong 5Y growth trend
Watchpoints
No urgent risks highlighted.
Health
30/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 4/9 indicates stability
Watchpoints
  • Debt/Equity ratio of 9.88 is dangerously high
  • Quick ratio below 1.0
Dividend
40/100

Ref Yield, Payout

Positives
  • Very low payout ratio (15.27%) suggests room for growth
Watchpoints
  • Low dividend yield (1.14%)
  • Low overall dividend strength score (25/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$53.2
Analyst Target
$55.0
Upside/Downside
+3.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MRX and closest competitors.

Updated 2026-04-14
MRX
Marex Group plc
Primary
5Y
+188.9%
3Y
+188.9%
1Y
+40.5%
6M
+70.5%
1M
+51.5%
1W
+13.3%
BAN
BancFirst Corporation
Peer
5Y
+76.0%
3Y
+44.0%
1Y
+8.3%
6M
-7.1%
1M
+5.8%
1W
+0.0%
IND
Independent Bank Corp.
Peer
5Y
+14.0%
3Y
+41.0%
1Y
+48.8%
6M
+18.9%
1M
+7.2%
1W
-0.9%
MAR
MARA Holdings, Inc.
Peer
5Y
-75.9%
3Y
-13.4%
1Y
-20.0%
6M
-48.8%
1M
+11.2%
1W
+17.1%
AGO
Assured Guaranty Ltd.
Peer
5Y
+143.2%
3Y
+41.2%
1Y
-8.7%
6M
-1.1%
1M
-8.4%
1W
-2.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
13.57
Forward P/E
10.02
PEG Ratio
N/A
P/B Ratio
3.27
P/S Ratio
1.33
EV/Revenue
1.58
EV/EBITDA
N/A
Market Cap
$3.82B

Profitability

Profit margins and return metrics

Profit Margin 10.71%
Operating Margin 19.45%
Gross Margin 70.54%
ROE 27.48%
ROA 1.04%

Growth

Revenue and earnings growth rates

Revenue Growth -51.4%
Earnings Growth +72.9%
Q/Q Revenue Growth +26.93%
Q/Q Earnings Growth +50.4%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
9.88
High debt
Current Ratio
1.08
Good
Quick Ratio
0.74
Poor
Cash/Share
$163.99

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$2.2B
Gross Margin
52.5%
Op. Margin
40.5%
Net Margin
3.9%
Total Assets
$34.7B
Liabilities
$33.4B
Equity
$1.3B
Debt/Equity
26.44x

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-14
$N/A
2026-03-03
$1.13
+10.5% surprise
2025-11-06
$0.92
-4.0% surprise
2025-08-13
$1.02
+10.1% surprise

Financial Services Sector Comparison

Comparing MRX against 484 companies in the Financial Services sector (87 bullish, 202 neutral, 195 bearish)
P/E Ratio
13.57
This Stock
vs
46.02
Sector Avg
-70.5% (Discount)
Return on Equity (ROE)
27.48%
This Stock
vs
0.23%
Sector Avg
+11915.1% (Excellent)
Profit Margin
10.71%
This Stock
vs
50.44%
Sector Avg
-78.8% (Weaker)
Debt to Equity
9.88
This Stock
vs
1.37
Sector Avg
+619.3% (Higher)
Revenue Growth
-51.4%
This Stock
vs
37.35%
Sector Avg
-237.6% (Slower)
Current Ratio
1.08
This Stock
vs
3.28
Sector Avg
-67.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

VAN DEN BORN SIMON JAMES
President
Sell
2026-04-01
13,264 shares · $577,105
TEXIER THOMAS HUGUES
Officer
Sell
2026-04-01
14,427 shares · $627,715
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
8 analysts
UBS
2026-04-02
Maintains
Buy Buy
TD Cowen
2026-03-27
Maintains
Buy Buy
Barclays
2026-03-27
Maintains
Overweight Overweight
Barclays
2026-03-04
Maintains
Overweight Overweight
TD Cowen
2026-01-14
Maintains
Buy Buy
Piper Sandler
2026-01-14
Maintains
Overweight Overweight
Barclays
2026-01-08
Maintains
Overweight Overweight
Barclays
2025-12-12
Maintains
Overweight Overweight
Goldman Sachs
2025-11-07
Maintains
Buy Buy
Barclays
2025-11-07
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning MRX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile